Maxcyte (MXCT) Gross Margin (2020 - 2026)

Maxcyte (MXCT) reported Gross Margin of 83.74% for Q1 2026, down 7111.0% year-over-year from 1.19% in Q1 2025, and up 170.19% on a QoQ basis from 119.31% in Q4 2025.

Maxcyte (MXCT) has 7 years of Gross Margin data on file, last reported at 83.74% in Q1 2026.

  • Quarterly Gross Margin fell 7111.0% year-over-year to 83.74% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 148.23% (up 3765.0% YoY) and the FY2025 annual result came in at 127.9%, up 4628.0% from the prior year.
  • Gross Margin improved to 83.74% in Q1 2026 per MXCT's latest filing, from 119.31% in the prior quarter.
  • Across five years, Gross Margin topped out at 296.3% in Q4 2023 and bottomed at 352.02% in Q4 2022.
  • The 5-year median for Gross Margin is 90.83% (2022), against an average of 87.54%.
  • The widest annual swing landed in 2023, when Gross Margin surged 64832 bps; it then plunged 22254 bps in 2024.
  • Tracing MXCT's Gross Margin over 5 years: stood at 352.02% in 2022, then soared by 184 bps to 296.3% in 2023, then sank by 75 bps to 73.76% in 2024, then sank by 262 bps to 119.31% in 2025, then surged by 170 bps to 83.74% in 2026.
  • Per Business Quant, the three latest MXCT Gross Margin figures stand at 83.74% (Q1 2026), 119.31% (Q4 2025), and 76.63% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 56.20%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 63.29%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 63.83%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 69.46%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 78.01%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 45.22%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 62.95%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 38.53%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 43.89%
10 Maxcyte 129.85 Mn 129.85 Mn 8.08 Mn 83.74%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 83.74%
Dec 31, 2025 -119.31%
Sep 30, 2025 76.63%
Jun 30, 2025 119.99%
Mar 31, 2025 154.85%
Dec 31, 2024 73.76%
Sep 30, 2024 76.38%
Jun 30, 2024 180.12%
Mar 31, 2024 177.99%
Dec 31, 2023 296.30%
Sep 30, 2023 173.51%
Jun 30, 2023 84.78%
Mar 31, 2023 152.62%
Dec 31, 2022 -352.02%
Sep 30, 2022 129.66%
Jun 30, 2022 88.34%
Mar 31, 2022 90.83%
Dec 31, 2021 -411.21%
Sep 30, 2021 163.95%
Jun 30, 2021 88.96%
Mar 31, 2021 136.87%
Dec 31, 2020 -345.24%
Sep 30, 2020 129.10%
Jun 30, 2020 201.35%